RxDoctor Payments Data
★ My doctorsLook up a doctor →

Lee Kinsinger

Family Medicine · Washington, ILNPI 1417983487

Payments from drug & device makers

$2,591in general payments, 2019–2025

Across 165 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$277
  • Novartis$275
  • AstraZeneca$257
  • Boehringer Ingelheim$256
  • Pfizer$247
  • GSK$167
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$2,51097%
  • Education$813%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott23$277
Novartis11$275
AstraZeneca10$257
Boehringer Ingelheim16$256
Pfizer27$247
GSK13$167
Boston Scientific1$137
AbbVie7$128
Astellas Pharma US Inc5$113
Sanofi-aventis U.S. LLC8$109
Lilly USA, LLC6$88
Supernus Pharmaceuticals, Inc.6$79
Novo Nordisk4$56
Biohaven Pharmaceuticals, Inc.3$54
E.r. Squibb & Sons, L.L.C.4$51
Jazz Pharmaceuticals Inc.3$50
Amgen3$46
Amarin Pharma, Inc.3$43
Johnson & Johnson3$40
Radius Health, Inc.2$31
Takeda Pharmaceuticals U.S.A., Inc.2$27
Teva Pharmaceuticals USA, Inc.2$23
Bayer1$13
Shire North American Group Inc1$13
Merck1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,591 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois →

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$28,194
JardianceEmpagliflozin16$13,057
FarxigaDapagliflozin Propanediol11$8,227
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,203
SynthroidLevothyroxine Sodium13$1,341
Rosuvastatin Calcium93$1,022
Levothyroxine Sodium110$890
Losartan Potassium87$850
Gabapentin37$818
Atorvastatin Calcium78$705
Montelukast Sodium37$627
Metoprolol Succinate41$507
Omeprazole36$478
Metformin Hcl ErMetformin Hcl41$368
Amlodipine Besylate56$362

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$247$28,19440 claims
Boehringer IngelheimJardiance, Stiolto Respimat$256$18,26027 claims
AstraZenecaFarxiga$257$8,22711 claims
AbbVieSynthroid$128$1,34113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Washington

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →